The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

"Palatin concludes Phase II trial of combination therapy for obesity" was originally created and published by Clinical Trials ...

CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...

Whether you're hosting a Super Bowl party or want to connect an outdoor security system, extending your Wi-Fi signal outside doesn't have to be complicated. Trey Paul is a CNET senior editor ...

Last Patient / Last Visit Completed Topline Data Readout Expected Later This Quarter CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc.

CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical ... Genetic mutations that inhibit signaling in the MC4R pathway lead to ...

CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company ... Genetic mutations that inhibit signaling in the MC4R pathway lead to ...

SANTA CLARA, CA, UNITED STATES, February 4, 2025 /EINPresswire.com/ -- India's Vision for Job Creation, Economic Development, and Global Positioning: A Detailed Look ...